Instituto de Oncologia de Sorocaba

What Instituto de Oncologia de Sorocaba does

Instituto de Oncologia de Sorocaba (IOS), legally 'Instituto de Oncologia de Sorocaba Dr. Gilson Delgado,' is a private outpatient oncology center founded in 1995 and headquartered in Sorocaba, São Paulo, Brazil. The institution operates two coordinated sites — Centro de Medicina e Saúde on Avenida Comendador Pereira Inácio and a second location inside Hospital Evangélico de Sorocaba — providing specialized oncology consultations, ambulatory chemotherapy, immunotherapy, hormone therapy, targeted therapy, oral antineoplastic dispensing, fully implantable catheter maintenance, and oncogenetics risk assessment. A separate Centro de Infusão IOS extends services beyond oncology to immunobiological therapies for autoimmune and chronic inflammatory conditions including rheumatoid arthritis, Crohn's disease, psoriasis, lupus, multiple sclerosis, vasculitis, and osteoporosis. The facility runs 8 consultation rooms, 11 infusion rooms, and 1 emergency room, supported by 17 specialist physicians across hematology, mastology, oncogenetics, oncology, and rheumatology, plus a multidisciplinary team of pharmacists, nurses, nutritionists, and psychologists who conduct monthly clinical case reviews.

IOS operates as part of Hospital Care's Hub Sorocaba network, integrated with Hospital Evangélico de Sorocaba for a complete inpatient-outpatient oncology patient journey. Revenue is generated through fee-for-service reimbursements from 22+ Brazilian health insurance plans (Amil, Bradesco Saúde, Unimed, SulAmérica, Porto Seguro, Golden Cross, Cassi, Geap, Notre Dame, Care Plus, and others) plus private-pay arrangements for uninsured patients. Patient acquisition relies on physician referrals, insurance pre-authorization, WhatsApp booking, online scheduling, and a content/blog presence tied to Hospital Evangélico. IOS holds ACSA international quality accreditation (since late 2021), making it the second oncology institution in Brazil to obtain this European certification. The center is led by Dr. Luis Antonio Pires as Technical-Medical Director, and operates as a private entity within the Hospital Care portfolio with no publicly disclosed financial information, no public listing, and no external investors identified in the source data.

The business model is a regionally anchored specialty care delivery platform: clinical capacity is fixed (physical rooms, specialist roster), revenue is variable based on insurance and private-pay patient throughput, and growth levers are service-line breadth (oncology plus autoimmune infusions) and digital patient access rather than geographic expansion. No technology platform, software products, AI capabilities, or proprietary intellectual property beyond clinical accreditation and brand reputation are documented.

Name

Instituto de Oncologia de Sorocaba

Legal name

Instituto de Oncologia de Sorocaba

Website

https://oncologiasorocaba.com.br

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

Instituto de Oncologia de Sorocaba is a private outpatient oncology center in Sorocaba, Brazil, offering chemotherapy, immunotherapy, infusion therapy, and oncogenetics to regional patients via two Hospital Care-integrated sites and 22+ insurance plans.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Outpatient Care Centers (6214), Offices of Physicians (62111), Other Outpatient Care Centers (62149)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industry

Infusion Therapy Centers (Outpatient) (HLAFABAF)

Keywords

• Oncology treatment services
• Chemotherapy infusions
• Immunotherapy services
• Cancer care specialties
• Immunobiological infusion therapy

Headquarters

HQ city

Sorocaba

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Others

Revenue model

1. Health Insurance / SUS Reimbursements: IOS accepts over 22 health insurance plans (convênios) including Amil, Bradesco Saúde, Unimed, SulAmérica, Porto Seguro, Golden Cross, Cassi, Geap, Notre Dame, Care Plus, and others. Revenue is generated through reimbursements from health insurance providers for consultations, chemotherapy, and infusion treatments, as well as private/pay-per-visit arrangements.
2. Private/Particular Patient Payments: The facility also serves private-paying patients not covered by insurance, offering individual consultations and treatments at accessible rates, with complete process guidance provided.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Instituto de Oncologia de Sorocaba is a specialized outpatient oncology center providing cancer consultations, chemotherapy (intravenous, oral, intramuscular, subcutaneous), hormone therapy, immunotherapy, and targeted therapy. The facility also operates a dedicated Centro de Infusão (Infusion Center) that administers immunobiological and non-oncological infusions for patients with autoimmune and chronic inflammatory diseases. Services are delivered through 8 consultation rooms, 11 infusion rooms, and 1 emergency room, with pharmaceutical oral medication dispensing and fully implantable catheter maintenance as ancillary offerings.

Product overview

Instituto de Oncologia de Sorocaba (IOS) is a specialized oncology center offering a comprehensive range of cancer treatment services and related medical specialties. The core offerings include consultations and chemotherapy treatments, supplemented by a dedicated Centro de Infusão for immunobiological and non-oncological therapies. Treatment services encompass hormonotherapy, immunotherapy, targeted therapy, oral medication dispensing, and catheter maintenance. The institute provides five medical specialties: Hematology, Mastology, Oncogenetics, Oncology, and Rheumatology. IOS operates with a multidisciplinary team including doctors, pharmacists, nurses, nutritionists, and psychologists, and is integrated with Hospital Evangélico de Sorocaba as part of the Hospital Care network Hub Sorocaba.

Differentiator

Problem solved

Functional benefit

Products and services

• Consultas e Quimioterapias Oncology consultations and chemotherapy treatments offered for over 28 years, with individualized patient care and follow-up by dedicated physicians, delivered at the IOS Centro de Medicina e Saúde facility in Sorocaba.
• Centro de Infusão IOS Specialized infusion center for immunobiological therapies and non-oncological treatments administered via intravenous, intramuscular, or subcutaneous routes for patients with autoimmune and inflammatory diseases including rheumatoid arthritis, Crohn's disease, psoriasis, lupus, multiple sclerosis, vasculitis, and osteoporosis.
• Quimioterapia (Chemotherapy) Antineoplastic chemotherapy using medications that target tumor cells to destroy them, inhibit growth, or relieve symptoms caused by tumor development, administered in 11 dedicated infusion rooms.
• Hormonioterapia (Hormone Therapy) Hormone or endocrine therapy that blocks estrogen and progesterone from binding to cancer cell receptors, primarily used for hormone-sensitive breast cancer treatment.
• Imunoterapia (Immunotherapy) Immunotherapy that stimulates the immune system to enhance the body's ability to fight diseases, either by strengthening natural defenses or marking diseased cells for identification and attack.
• Terapia-alvo (Targeted Therapy) Targeted therapy using drugs designed to specifically attack cancer cell changes, working differently from chemotherapy drugs with different side effect profiles.
• Dispensação de Medicamento Oral Pharmaceutical dispensing service for oral antineoplastic medications, including patient education on correct medication use with emphasis on safety and error minimization, with pharmaceutical professionals providing guidance.
• Manutenção de Cateter Totalmente Implantável Fully implantable catheter maintenance service for chemotherapy administration, ensuring catheter patency and preventing complications from drug interactions.
• Hematologia Medical specialty dedicated to the study of blood and related pathologies, including production of blood elements and diseases affecting the hematopoietic system.
• Mastologia Medical specialty focused on breast diseases including anatomical and physiological changes, benign and malignant conditions, with emphasis on breast cancer prevention, diagnosis, and treatment.
• Oncogenética Genetic oncology specialty that reviews patient and family cancer history to assess predisposition to neoplasms, enabling preventive and early-detection strategies.
• Oncologia (Clinical Oncology) Medical specialty studying cancer (malignant tumors) and how these diseases develop in the body, encompassing treatment options including chemotherapy, hormone therapy, and immunotherapy coordination.
• Reumatologia Medical specialty focused on rheumatic diseases including autoimmune and inflammatory conditions affecting joints, muscles, and connective tissues, supporting referrals to the Centro de Infusão for non-oncological immunobiological therapies.

Quantifiable outcome

• 28+ years serving as a regional oncology reference center in Sorocaba and region.
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Hospital Evangélico de SorocabacoreStrategic or Co-development PartnerIOS integrates with Hospital Evangélico de Sorocaba as part of the Hub Sorocaba of Hospital Care. This partnership enables a complete, integrated patient journey with IOS specialists and hospital services coordinating across all treatment stages. The two institutions operate in coordination providing comprehensive oncology and general healthcare services.
• Hospital CarecoreStrategic or Co-development PartnerIOS integrates the Hub Sorocaba of Hospital Care, one of Brazil's largest healthcare service administrators. This affiliation provides IOS with institutional backing, operational scale, and the ability to offer patients a comprehensive care journey through integration with multiple healthcare facilities and services within the Hospital Care network.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• BP - A Beneficência Portuguesa de São Paulo: Large São Paulo general hospital with established oncology services. Comparable for competing oncology referrals from the São Paulo interior, though it operates a broader portfolio of medical specialties beyond cancer.
• Hospital Israelita Albert Einstein: Major São Paulo-based general hospital with a strong oncology program. Comparable as an oncology service provider competing for the same São Paulo state patient pool, but operating as part of a much broader hospital and research enterprise.
• Hospital Moinhos de Vento: Major hospital in southern Brazil with an oncology center. Comparable as a private hospital offering chemotherapy and infusion services within an integrated care model, though regionally distant from IOS's territory.
• Hospital Sírio-Libanês: Premium São Paulo general hospital with a dedicated oncology center. Comparable for high-acuity oncology patients who might otherwise be referred from Sorocaba to the capital; broader scope than IOS but competes for the same tertiary cancer cases.

Direct peers

• Grupo Oncologia D'Or: Network of oncology clinics operated within Rede D'Or São Luiz hospitals. Comparable as outpatient oncology and infusion services, with similar integration into broader hospital systems and Brazilian private insurance networks.
• Hospital de Amor (Barretos): Large oncology-specialty hospital in interior São Paulo state. Comparable as a cancer-focused institution serving the São Paulo interior, including chemotherapy and outpatient infusion services, with similar regional referral dynamics.
• Oncoclínicas Group: Brazil's largest dedicated oncology clinic network, operating outpatient chemotherapy and infusion centers across multiple states. Most directly comparable to IOS as a specialty outpatient oncology operator with multiple locations and insurance contracts.
• A.C. Camargo Cancer Center: One of Brazil's largest specialized oncology hospitals, headquartered in São Paulo. Comparable as a comprehensive oncology center offering chemotherapy, immunotherapy, and multidisciplinary cancer care, though at a much larger scale and serving as a national reference rather than regional.

Others

• Hospital Care (Parent Network): Parent hospital network of which IOS is the Hub Sorocaba. Comparable as the broader healthcare service platform whose strategic decisions shape IOS's expansion and integration opportunities, though it operates many non-oncology facilities.

Regional players

• Centro de Oncologia de Campinas: Specialty outpatient oncology center in Campinas (interior São Paulo). Comparable in scale and service mix to IOS — outpatient chemotherapy and infusion — but serving a different nearby regional market rather than directly competing in Sorocaba.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/InstitutodeOncologiadeSorocaba
• LinkedInlinkedin.com/company/instituto-de-oncologia-de-sorocaba
• Instagraminstagram.com/institutooncologiaios

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto de Oncologia de Sorocaba